Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
about
Lung microbiology and exacerbations in COPDTreatment of obstructive sleep apnoea for chronic cough in childrenMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseProtocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approachRhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids.SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling.Sputum myeloperoxidase in chronic obstructive pulmonary disease.Extracellular cyclophilin levels associate with parameters of asthma in phenotypic clustersDomiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot studyEffect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease.Dynamics of inflammation resolution and symptom recovery during AECOPD treatment.Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease.Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary diseaseInflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzaeICON: chronic rhinosinusitis.Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.The effects of Gamijinhae-tang on elastase/lipopolysaccharide-induced lung inflammation in an animal model of acute lung injuryAssociation between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort.Effect of gene environment interactions on lung function and cardiovascular disease in COPD.Airway inflammation contributes to health status in COPD: a cross-sectional study.Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosisSerum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary diseaseUsing the Electronic Nose to Identify Airway Infection during COPD Exacerbations.Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease.Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trialSystemic inflammation and lung function in young adults.What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.Bronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa.Vitamin D deficiency, smoking, and lung function in the Normative Aging Study.Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease.Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trialNasal and sinus inflammation in chronic obstructive pulmonary disease.
P2860
Q22305860-4EDE6377-A73B-4B52-A30C-8BA73D1B5908Q24235083-FF39430D-0C2E-4FFE-8AEF-BE1D85EC0AA8Q27000043-E2590D58-02FC-477D-9C72-FF93806CAEA3Q28650506-3DBCBEA5-7864-4963-895B-28CFDA166FFEQ30480513-BF1A3A61-0A57-4CA2-A95D-939DA4AA361AQ33576194-97D24DFD-3A64-4ED9-8AF6-50650E458BADQ33592946-18058752-FDE5-4C78-8F4C-06B48AF88752Q33713360-84031A70-42AE-4640-A4CD-655026C5AE6DQ33723544-E51560ED-D72D-4289-9D89-C9E721CCEA2BQ33757519-82A9837A-7EB6-4B87-9E7C-95661697314EQ33827166-D29680A9-43EA-4A69-9FB6-02696FCD7818Q34065677-83133945-49B6-42EC-B85F-203FCE9AC9FFQ34171117-734F8894-A738-443B-ADD6-FF1986738A0BQ34234995-CBF747E4-862E-4050-9EF1-A8B6036C6025Q34287563-674FF2C4-F6FB-4633-A638-87A41917B0B1Q34386841-A9E546C7-C765-460A-A6E0-BE5C970ADAEBQ34423484-75BEC08B-D055-4E41-9E5E-120E766D7440Q34684239-C1AE92B9-1EBE-4C76-ADE3-33DCDD3F60C0Q34834259-90E097BA-2C44-4EBE-B311-6205E9492842Q34840443-E318CD8B-A9E8-43C0-8AD7-5BC63AB0A109Q34840845-4D069B45-C207-41B0-BC0D-F9F8698C97A8Q34914760-4568878A-E854-4C00-80BA-98212577D575Q35131487-3F00B542-CF1C-46BD-BD5F-60A0FC17A84EQ35220025-BB2470BE-667E-4909-A1CF-77AC5355F9DBQ35557425-2CE712C3-8D93-4595-B7DC-05FC7FFA51DDQ35637295-7F3CCCAB-C60C-477B-B8CA-B68A7DE9E555Q35677638-A820901A-5AD6-46BB-890C-0CB837F5300CQ35734988-210580E6-81EE-4DC0-BDD7-B816D0CAD016Q35768180-2EB3C0C2-DF12-4FE4-8ED9-C4F70E09F472Q35794462-9D637BF4-8F67-423C-BF8F-05D70D3EADCDQ35825949-93397CB8-5A24-47D7-89CD-177F642A2D20Q36150134-A38C562C-CF57-44ED-AB82-24F7D2A78383Q36169109-7210F59F-1E58-4C76-BC41-2C74E0C8391AQ36225586-36BBAAF0-C6C0-421F-8123-AB818E8C6D28Q36321964-E1EDC51C-37DB-455D-8A47-595E86206CF2Q36345260-3B389D1E-5149-4309-9DE8-FC277B66164EQ36379352-D0588E4A-10F8-4CB8-95D2-627F5035A9DDQ36464916-A967D290-4F6D-4726-B4BB-DC50D88E711AQ36695712-551B677D-1270-4940-ABA4-E98C82A0CAC5Q36832384-F243AAB2-7C0C-4538-8D40-31445214028D
P2860
Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Systemic and upper and lower a ...... obstructive pulmonary disease.
@en
Systemic and upper and lower a ...... obstructive pulmonary disease.
@nl
type
label
Systemic and upper and lower a ...... obstructive pulmonary disease.
@en
Systemic and upper and lower a ...... obstructive pulmonary disease.
@nl
prefLabel
Systemic and upper and lower a ...... obstructive pulmonary disease.
@en
Systemic and upper and lower a ...... obstructive pulmonary disease.
@nl
P2093
P1476
Systemic and upper and lower a ...... obstructive pulmonary disease.
@en
P2093
Gavin C Donaldson
Jadwiga A Wedzicha
John R Hurst
Tom M A Wilkinson
Wayomi R Perera
P356
10.1164/RCCM.200505-704OC
P407
P577
2005-09-22T00:00:00Z